Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration
- 1 January 2004
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 125 (2) , 317-327
- https://doi.org/10.1016/j.neuroscience.2004.01.045
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Cyclooxygenase-2 Regulates Prostaglandin E2Signaling in Hippocampal Long-Term Synaptic PlasticityJournal of Neurophysiology, 2002
- Pharmacology of Celecoxib in Rat Brain after Kainate AdministrationThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Direct Activation of Rat Spinal Dorsal Horn Neurons by Prostaglandin E2Journal of Neuroscience, 2001
- Phenobarbital pre-treatment prevents kainic acid-induced impairments in acquisition learningLife Sciences, 2000
- Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampusBrain Research, 1999
- Neuropharmacology of AMPA and kainate receptorsNeuropharmacology, 1998
- Prostaglandin E2 protects cultured cortical neurons against
methyl -d -aspartate receptor-mediated glutamate cytotoxicityBrain Research, 1994 - The cyclooxygenase and lipoxygenase inhibitor BW755C protects rats against kainic acid-induced seizures and neurotoxicityBrain Research, 1994
- Protection by prostaglandins from glutamate toxicity in cortical neuronsNeurochemistry International, 1994
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976